Clinical application of cVEMPs and oVEMPs in patients affected by Ménière’s disease, vestibular neuritis and benign paroxysmal positional vertigo: a systematic review
Vestibular evoked myogenic potentials (VEMPs) are increasingly used for different pathologies with new clinical insights. Although the study of otolithic function selectively in both its saccular (cervical VEMPs) and utricular (ocular VEMPs) parts does not represent a recent achievement, the clinical utility of this tool is still emerging. The aim of the present report is to define advances in application of VEMPs in diagnosis and clinical study of vestibular neuritis, Ménière’s disease and benign paroxysmal positional vertigo. To perform a systematic review of the literature, three appropriate strings were run in PubMed to retrieve dedicated articles. A double cross-check was performed on citations and two independent investigators independently reviewed all full-text articles and performed a comprehensive quality assessment. Of 140 articles identified, 26 articles were included, comprising a total of 1,181 patients affected by vestibular neuritis (296 subjects), Ménière’s disease (378 patients) and benign paroxysmal positional vertigo (507 patients). Overall, the use of both cVEMP and oVEMP appeared particularly useful in improving the topographic diagnosis of vestibular neuritis. Most (n = 8) of the studies dedicated to Ménière’s disease and benign paroxysmal positional vertigo (10 overall) also reported significantly abnormal VEMP values compared to healthy controls. Although further reports will be necessary to better define normal threshold levels of VEMPs for each pathology, our review suggests that VEMPs may represent a useful aid in improving the diagnostic accuracy for these three common vestibular pathologies.
Vestibular evoked myogenic potentials (VEMPs) are short latency electromyographic responses that can be recorded from various muscles during the contraction phase in response to acoustic stimulus. VEMPs recorded from ipsilateral sternocleidomastoid muscle known as “cervical VEMP” (cVEMP) are a clinical demonstration of the vestibulo-collic reflex. cVEMP responses are characterised by biphasic waves with initial positivity (p13) followed by a negative wave (n23). The cVEMP pathway is believed to originate in the saccular macula and continues through the vestibular nerve and nucleus, vestibulospinal tracts, spinal motor nucleus and the sternocleidomastoid muscles 1.
Recently, a myogenic response recorded from contralateral extraocular muscles in response to acoustic stimuli has been reported to be a manifestation of crossed vestibulo-ocular reflex and named ‘‘ocular VEMP’’ (oVEMP). The oVEMP pathway is thought to travel through the medial longitudinal fasciculus, oculomotor nuclei and nerves and extraocular muscles after the activation of the vestibular nerve and nucleus 2. oVEMP responses are characterised by biphasic waves with an initial negative peak (n1) followed by a positive peak (p1) 1.
The study of otolithic function in both its saccular (cVEMPs) and utricular (oVEMPs) parts represents a milestone similar to that marked by the introduction of the caloric test, as the diagnosis and prognosis of numerous vestibular diseases can be influenced by such findings 3. Moreover, VEMP recording is a simple and rapid method that is well tolerated by subjects, and easily implementable in a laboratory equipped for recording evoked potentials. For these reasons, the VEMP recording test has become an important diagnostic tool, particularly in evaluation of peripheral vestibular disorders.
At present, cVEMP responses have been shown to be particularly useful in assessment of patients with “superior semicircular canal dehiscence” presenting a lower-than-normal threshold for elicitation of the cVEMP response in the affected ear 4. However, VEMPs are also thought to provide useful information about brainstem functions, as the neural pathway of both VEMPs pass through the brainstem, and several studies have described cVEMP and oVEMP abnormalities in brainstem lesions 5-7.
Undoubtedly, in recent years the popularity of this type of vestibular testing is on the increase, and different reports have been published about the utility of VEMPs in vestibular and otologic pathologies.
The aim of this systematic review was to define the advances of the application of VEMPs to three frequent vestibular pathologies, as outlined in the recent literature.
Materials and methods
In April 2017, a computerised MEDLINE search was performed using the PubMed service of the U.S. National Library of Medicine; the following 3 search strings were run:
- “Ménière Disease”[Mesh] OR “Endolymphatic Hydrops”[Mesh] AND “Vestibular Evoked Myogenic Potentials”[Mesh];
- “Vestibular Neuronitis”[Mesh] OR “Vestibular neuritis”[Mesh] AND “Vestibular Evoked Myogenic Potentials”[Mesh];
- “Benign Paroxysmal Positional Vertigo”[Mesh] AND “Vestibular Evoked Myogenic Potentials”[Mesh].
Overall, the initial search returned a total of 140 results. Abstracts and titles obtained were screened independently by two of the authors (F.M.G. and M.R.), who subsequently met to discuss disagreements on citation inclusion.
Inclusion criteria for citations were: articles reporting sufficient number of patients (> 10 subjects).
Exclusion criteria for citations were: analysis including cohorts of patients affected by others vestibular pathologies; articles concerning different instrumental methods than cVEMPs or oVEMPs.
Of the 140 articles, 36 met initial inclusion criteria according to both authors (FMG and MR), and were thus obtained and reviewed in detail by the same two authors, who met and discussed disagreements on article inclusion. Inclusion criteria for full text articles identified were: sufficient and accurate description of VEMPs recording system; sufficient and accurate description of pathologies and clinical features.
Exclusion criteria were: lack of sufficient analysis and presentation of data; inclusion of patients with probable or not definite diagnosis.
A total of 12 studies were excluded because of insufficient data about recording VEMPs (n = 4), lack of sufficient analysis of presented data (n = 6), or patient redundancy (n = 2).
An additional manual check was performed on the references included in the articles and two additional studies were identified and confirmed to meet the inclusion criteria. The main information was extracted and analysed for all included studies.
After an initial check, full-text retrieval and manual cross-checking of references included in the articles, a total of 26 studies, including 1181 subjects, clearly met the inclusion criteria and were chosen for analysis (Figure 1). The main characteristics of these selected studies are outlined in Tables I, II and III.
Overall, the number of patients in each study included in this analysis varied from 12 to 134. There were 6 studies (including 296 patients) investigating VN, 10 studies (including 378 patients) dedicated to MD and 13 studies (including 507 patients) investigating BPPV.
All VN dedicated studies performed cVEMPs, while oVEMPs responses were recorded in only 3 of the studies. Of the 10 MD studies, cVEMPs was performed in 7 and oVEMPs in 3 studies. Of the 13 articles analysing BPPV patients, 8 investigated cVEMPs while only 1 study reported recording oVEMPs.
Overall, abnormal VEMPs recording rates for VN ranged from 36.6% to 80% (Table I). A significant correlation between the presence of VEMPs abnormalities and pathology was reported in 5 of the MD studies; amplitude reduction was the most frequently observed alteration (Table II). Furthermore, half of the BPPV articles (4/8) found a significant correlation between affected patients and VEMP abnormalities compared to control groups (Table III).
The vestibular nerve is composed of the superior vestibular nerve (utricular nerve and superior and lateral ampullary nerves) and the inferior vestibular nerve (saccular nerve and posterior ampullary nerve) 8. Vestibular neuritis (VN) is a clinical entity defined by an episode of prolonged vertigo associated with unilateral peripheral vestibular hypofunction 9. It may affect either the entire vestibular nerve or each division of the vestibular nerve separately 10.
In patients who present selective involvement of the superior vestibular nerve (superior VN), the function of the horizontal and anterior canals is impaired, as shown by abnormal calorics and deficient head-impulse tests in the plane of the involved horizontal and anterior canals 11.
In such patients, the utricular afferents that traverse the superior vestibular nerve are likely to have absent or reduced function. However, the function of the inferior division of the vestibular nerve is spared, as shown by normal head-impulse tests during stimulation of the posterior canal and normal cVEMP 12 13.
By contrast, VN selectively affecting the inferior division may show reduced or absent ipsilesional cVEMP in the presence of functioning horizontal and anterior semicircular canals and utricle, as determined by normal calorics and horizontal head-impulse tests 14.
Functional impairment of the entire vestibular nerve (superior and inferior division) and a single superior division involvement in VN are the most common conditions 15, and selective inferior vestibular nerve damage has recently been described 16.
Some authors have investigated the role of VEMPs recording in improving the diagnostic accuracy for patients affected by VN. Hong et al. 17 studied 134 patients with VN. Overall 49 (36.6%) showed an abnormal cVEMP response. In particular, a prolonged p13 latency was noted in 29 patients, while 25 patients presented a n23 prolonged latency. Increased cVEMP asymmetry was found in 27 patients. The authors speculated that 36.6% of all subjects in their study had lesions in the labyrinth or inferior vestibular nerve.
Vinciana et al. 18 analysed 41 patients diagnosed with VN. cVEMPs were performed and resulted abnormal in 21 (51%) of 41 cases, the most common finding was an increase in ipsilateral latencies for p1 and n1 peaks.
Further, Nola et al. 19 performed cVEMP recording in a cohort of 20 patients affected by VN. Nine patients, presenting a torsional nystagmus and bilateral normoreflexia after caloric labyrinth stimulation, had no cVEMP response on the affected side (while the response was present on the contralateral side). The authors concluded that these nine patients were affected by inferior VN.
The cVEMP examinations were then repeated after 8 days, 1 month and 3 months. After 8 days, seven of the patients diagnosed with inferior branch VN showed an improvement of cVEMP values while a complete reappearance of cVEMP after 1 month was noted in all nine patients.
The findings of Shin et al. 14 strongly support the hypothesis that oVEMPs response is mediated by the superior vestibular nerve. The authors examined 41 patients with acute VN, and on the basis of clinical findings (appearance of mixed horizontal and torsional nystagmus; impaired horizontal SCC function on head-impulse test and caloric paresis > 25%; normal cVEMP and normal head-impulse test for posterior SCC) 30 subjects affected by neuritis of the superior vestibular nerve were identified. Interestingly, all these patients presented normal cVEMP responses in the affected ear, indicating that the saccular otolithic receptors and their afferents, in the inferior vestibular nerve, were completely functional. In contrast, all 30 patients had an asymmetric oVEMP response with the p10 component either absent, markedly reduced or delayed, beneath the eye opposite to the affected ear.
In a recent study, Magliulo et al. 3 prospectively evaluated 40 patients affected by VN employing both cVEMPs and oVEMPs. Thirty-two of the 40 patients showed absent or abnormal oVEMPs at the first control, while only 19 of the 40 patients showed absent or abnormal values of cVEMPs. With the aid of the video head impulse test (vHIT) the authors were able to classify the various pathological findings with regards to the location of vestibular damage and number of vestibular organs involved. The superior vestibular nerve VN (30%), followed by the total VN (25%), were the most frequently involved entities.
Similary, Walther and Blodow 20 analysed 20 patients affected by VN using both oVEMPs and cVEMPs in combination with vHIT. The authors were able to differentiate 4 types of VN (entire VN; superior VN; inferior VN; ampullary VN); entire VN and superior VN were the entities most frequently observed.
Ménière’s disease (MD)
Ménière’s disease (MD) is characterised by fluctuating hearing loss, tinnitus, aural fullness and episodic vertigo 21 22. The histopathological correlate, endolymphatic hydrops, is observed most frequently in the cochlea and the saccule, followed by the utricle and the semi-circular canals 23-25.
The diagnosis of MD relies upon clinical presentation and pure tone audiometry, which in the early stages of the disease shows low frequency hearing loss in a “rising configuration” that later progresses to a flat hearing loss of moderate severity 26-29.
Current standard vestibular testing consists of caloric stimulation of both ears using nystagmography to evaluate the ear’s functionality. However, this test highlights disturbances in only 1 (the horizontal canal) of the 3 semi-circular canals. Moreover, in patients with MD, the calorigram can show variable responses, and in many cases, test results are normal 30.
Initial reports using a standard fixed acoustic stimulus showed that a significant number (35%-54%) of patients with MD did not have cVEMPs present 31-33, so that authors began to compare VEMPs values in patients affected by MD with those recorded in normal ears.
Akkuzu et al. 34 found 10 (50%) abnormal cVEMP responses in 20 patients with MD. In particular, there were 4 ears with no response while six ears presented a prolonged latency at p13. Among 29 subjects diagnosed with MD, Hong et al. 15 observed an abnormality of cVEMP in 20 (69%) of them. In particular, increased cVEMP asymmetry was noted in 14 (70%) patients followed by a prolonged p13 latency (9 patients, 45%).
Egami et al. 35 measuring cVEMP in 144 patients affected by MD and found abnormal values in 57 (50%) of them. It must be noted that among the same patients only 43 (37.7%) showed no or decreased caloric responses on the affected side.
Kingma et al. 36 measured cVEMP in 22 patients affected by MD. On average, significantly lower VEMP amplitudes were measured at the side of the affected ear for both stimulus frequencies (250 and 500 Hz).
Winters et al. 37 evaluated the changes of the oVEMP in a group of 37 patients with MD. The data showed that the oVEMP response rates in ears of patients with MD were dramatically lower (54% at 120 dB SPL; 29% at 115 dB SPL) than in normal subjects (98.2% at 120 dB SPL).
Taylor et al. 38 investigated the prevalence of cVEMP and oVEMP on 60 patients with MD reporting 50% of abnormality for oVEMP and 40% of abnormality for cVEMP responses.
Some authors 39 40 reported a shift in dominant frequency away from the typical 500 to 1000 Hz for VEMPs recorded in patients with MD. On the basis of these observations, Sandhu et al. 41 confirmed the presence of this shift in dominant frequency for both cVEMP and oVEMP in patients with MD. Interestingly, the authors were able to evoke myogenic potentials in all ears tested: in healthy volunteers, the acoustic stimulus frequency at which the response amplitudes were largest was 500 Hz, while in subjects affected by MD this value shifted to higher frequencies.
Similar results were observed by Kim-Lee et al. 42 who analysed the cVEMP responses in a group of 24 subjects with MD. Overall, cVEMP were present in 83% of affected ears, but were most reliably elicited at a tone burst stimulation frequency of 1,000 Hz. Moreover, the frequency peak amplitude ratios (FPA) in the MD group were significantly elevated compared with those of the control group. The authors concluded that FPA is elevated in MD and thus may represent a useful diagnostic criterion in the diagnosis of this pathology.
Another interesting study was published by Katayama et al. 43 who investigated the relationship between the presence of endolymphatic hydrops and cVEMP in patients with MD. Intratympanic injection with gadolinium diluted with saline was performed in 49 affected ears and after one day, 3 Tesla MRI and cVEMP were performed. Overall, cVEMP was present in 21 ears and absent in 28 ears. Endolymphatic hydrops was significantly associated with the absence of cVEMP.
Benign paroxysmal positional vertigo (BPPV)
Benign paroxysmal positional vertigo (BPPV) is the most common disorder of the peripheral vestibular system and characterised by episodes of vertigo associated with head movements 44 45. Although BPPV generally responds well to treatment, there is a significant rate of recurrence after the initial resolution 46. The recurrence rates during a 1-year follow-up period have been reported to range from 10% to 18% 47 48.
In explaining the pathophysiology of BPPV, the concept of a degenerative process that affects the macula of the utricle causing detachment of otoliths has gained popular support 49. However, in 30 affected ears with BPPV Akkuzu et al. 34 found 9 (30%) ears showing abnormal cVEMP values. This finding suggested that the degenerative process involved in BPPV might also affect the macula of the saccule.
Similarly, Boleas-Aguirre et al. 50 analysed 19 patients diagnosed with BPPV of the posterior semi-circular canal. The authors found a lack of cVEMP response in 52% of the affected ears. When adjusted for bilateral absence, cVEMP response was absent in 20.3% of ears. The authors concluded that some patients with BPPV show a certain degree of saccular dysfunction.
Among 62 subjects diagnosed with BPPV, Hong et al. 15 reported an abnormality of cVEMP in 16 (25.8%) of them. Yang et al. 51 investigated the clinical significance of cVEMP in a group of 41 patients affected by BPPV in comparison to 92 healthy volunteers. Overall, 11 (27%) patients in the BPPV group showed no response in VEMPs in the affected ear. Moreover, VEMPs showed prolonged p13 and n23 latencies in BPPV subjects compared with those of the control group.
Korres et al. 52 analysed 27 BPPV patients and noted that the percentage of abnormal cVEMP in the BPPV population was significantly higher than in the ears of control group.
Lee et al. 53 investigated the usefulness of VEMP in patients presenting recurrent BPPV and reported interesting results. The authors analysed 16 subjects presenting recurrent BPPV and 20 patients with non-recurrent BPPV by cVEMP and oVEMP. Among the group of patients with recurrent BPPV, abnormal cVEMP responses were detected in 5 (31.3%) subjects, while abnormal oVEMP responses resulted in 4 (25%) subjects. Between the 20 patients with non-recurrent BPPV, only 3 (15%) subjects overall showed abnormal cVEMP or abnormal oVEMP. Yetiser et al. 54 recently analysed a cohort of 102 patients affected by BPPV and reported similar findings. In total, 24 (23.5%) patients presented a gross cVEMP abnormality (absence of VEMP in 6 and greater than 25% depression of the amplitude in 18). Abnormality of VEMPs was not correlated with age, severity of nystagmus or the site of canal involvement, but was significantly correlated with persistence or recurrence of symptoms.
Finally, Longo et al. 55, in their prospective study of 23 patients affected by BPPV and 24 healthy volunteers, found that the cVEMP among BPPV patients were altered in 14 ears (30.4%) and absent in 5 (10.9%) affected ears and in 2 (4.3%) non-affected ears. This value was significantly higher than the comparative control groups.
Although official standard measurement parameters of normality must still be defined for VEMPs, it seems clear that this instrument will represent a novel and important vestibular examination for VP, MD and BPPV. In VN, VEMPs (cVEMP together with oVEMP) may represent a useful tool in improving topographic diagnosis, offering key information about prognosis and therapy. In MD, both cVEMP and oVEMP showed better sensitivity and specificity compared with the caloric test, but a wide variety of described alterations in VEMPs recordings among the studies analysed were noted, with amplitude reduction representing the most frequent finding. For this reason, additional studies are needed to accurately identify specific anomalies in VEMPs recording associated with MD. In VPPB, VEMPs may also be important in predicting pathological recurrences.
Figures and tables
|Authors||Year||No. of patients with definite VN||No. of healthy subjects in control group||Type of VEMPs||Sound conduction||Stimuli||Stimulation intensity||Stimulation frequencies||Significant findings in VEMPs responses|
|Hong et al. 17||2008||134||None||cVEMP||ACS||Clicks||95 dB||2,000 Hz||Abnormal values in 49 (36.6%) patients|
|Vinciana and Lopez-Escamez 18||2010||41||None||cVEMP||ACS||Tone bursts||129 dB||500 Hz||Abnormal values in 21 (51%) patients|
|Nola et al. 19||2011||20||None||cVEMP||ACS||n.a.||130 dB||500 Hz||Abnormal values in 9 (45%) patients|
|Shin et al. 14||2012||41||60||cVEMP||ACS||Tone bursts||100 dB||1,000 Hz||n.a.|
|oVEMP||ACS||Tone bursts||100 dB||1,000 Hz||Abnormal values in 30 (73.1%) patients|
|Walther and Blodow 20||2013||20||None||cVEMP||ACS||Tone bursts||100 dB||500 Hz||Abnormal values in 9 (45%) patients|
|oVEMP||ACS||Tone bursts||100 dB||500 Hz||Abnormal values in 12 (60%) patients|
|Magliulo et al. 3||2014||40||None||cVEMP||ACS||Logon||130 dB||500 Hz||Abnormal values in 19 (47.5%) patients|
|oVEMP||BCS||n.a.||n.a.||n.a.||Abnormal values in 32 (80%) patients|
|Authors||Year||No. of patients with definite MD||No. of healthy subjects in the control group||Type of VEMPs||Sound conduction||Stimuli||Stimulation intensity||Stimulation frequencies||Significant findings in VEMPs responses|
|Akkuzu et al. 34||2006||20||17||cVEMP||ACS||Tone bursts||100 dB||500 Hz||Abnormal values (p < 0.001)|
|Hong et al. 17||2008||29||None||cVEMP||ACS||Clicks||95 dB||2,000 Hz||Abnormal values in 20 (69%) patients|
|Kim-Lee et al. 42||2009||24||20||cVEMP||ACS||Tone bursts||90 dB||500-1,000 Hz||Elevated frequency peak amplitude (p < 0.001)|
|Winters et al. 37||2011||37||55||oVEMP||ACS||Tone bursts||120 dB||500-4,900 Hz||Lower response rate (p < 0.05)|
|Higher asymmetry ratio (p < 0.05)|
|Lower amplitude (p < 0.05)|
|Kingma and Wit 36||2011||22||None||cVEMP||ACS||Tone bursts||100 dB||250-500 Hz||Lower amplitude in the affected ears (p < 0.05)|
|Taylor et al. 38||2011||60||35||cVEMP||ACS||Clicks||140 dB||500 Hz||Abnormal values in 24 (40%) patients|
|BCS||Vibration pulses||n.a.||n.a.||Abnormal values in 13 (22.8%) patients|
|oVEMP||ACS||Clicks||140 dB||500 Hz||Abnormal values in 30 (50%) patients|
|BCS||Vibration pulses||n.a.||n.a.||Abnormal values in 6 (10.2%) patients|
|Sandhu et al. 41||2012||12||8||cVEMP||ACS||Tone bursts||120 dB||250-500-750-1,000-1,500-2,000-3,000-4,000 Hz||Lower amplitude (p < 0.05)|
|oVEMP||ACS||Tone bursts||120 dB||250-4,000 Hz||Lower amplitude (p < 0.05)|
|Egami et al. 35||2013||114||None||cVEMP||ACS||Clicks/Tone bursts||95 dB||500 Hz||Abnormal values in 57 (50%) patients|
|Silva et al. 61||2016||30||30||Combined cVEMP-oVEMP||ACS||Tone bursts||120 dB||500 Hz||Mean latency values of n10 - p15 waves were higher than control group|
|Chen et al. 62||2016||30||30||cVEMP||ACS||Tone bursts||90 dB||500 Hz||Abnormal responses in 12 (40%) patients|
|oVEMP||ACS||Tone bursts||95 dB||500 Hz||Abnormal responses in 5 (16.7%) patients|
|Authors||Year||No. of patients with definite BPPV||No. of healthy subjects in control group||Type of VEMPs||Sound conduction||Stimuli||Stimulation intensity||Stimulation frequencies||Significant findings and correlations in VEMPs responses|
|Akkuzu et al. 34||2006||25||17||cVEMP||ACS||Tone bursts||500 dB||500 Hz||Abnormal values (p=0.012)|
|Boleas-Aguirre et al. 50||2007||19||None||cVEMP||ACS||Clicks||70-100 dB||n.a.||Absent responses in 10 (52.4%) affected ears vs 5 (26.3%) healthy ears|
|Hong et al. 17||2008||62||None||cVEMP||ACS||Clicks||95 dB||500 Hz||Abnormal values in 24 (40%) patients|
|Yang et al. 51||2008||41||92||cVEMP||ACS||Clicks||95 dB||n.a.||No response in 11 (27%) patients; Prolonged latencies (p<0.001)|
|Korres et al. 52||2011||27||30||cVEMP||ACS||Tone bursts||95 dB||500 Hz||Abnormal values (p<0.005)|
|Longo et al. 55||2011||23||24||cVEMP||ACS||Logon||127 dB||500 Hz||Abnormal values (p<0.001)|
|Lee et al. 53||2013||16||None||cVEMP||ACS||Tone bursts||90 dB||500 Hz||Abnormal values in 5 (31.3%) patients|
|oVEMP||ACS||Tone bursts||95 dB||500 Hz||Abnormal values in 4 (25%) patients|
|Yetiser et al. 54||2014||102||15||cVEMP||ACS||Tone bursts||95 dB||500 Hz||Abnormal values in 24 (23.5%) patients|
|Xu et al. 56||2016||30||30||cVEMP||ACS||Tone bursts||90 dB||500 Hz||Abnormal values in 9 (30%) BPPV patients vs 2 (6.6%) healthy patients|
|oVEMP||ACS||Tone bursts||95 dB||500 Hz||Abnormal values in 17 (56.7%) BPPV patients vs 1 (3.3%) healthy patient|
|Singh et al. 57||2015||31||31||cVEMP||ACS||Tone bursts||125 dB||500 Hz||No significant group difference on any cVEMP parameters|
|oVEMP||ACS||Tone bursts||125 dB||500 Hz||Peak-to-peak amplitude significantly smaller in the affected ears|
|Chang et al. 58||2017||65||None||cVEMP||ACS||Tone bursts||95 dB||500 Hz||Decreased interaural amplitude difference ratio at the affect side associated with persisting BPPV after manoeuver|
|Hoseinabadi et al. 59||2015||30||None||cVEMP oVEMP||ACS||Tone bursts||95 dB||500 Hz||QoL is more compromised in patients with cVEMP and oVEMP abnormalities|
|Karatas et al. 60||2016||36||20||cVEMP||ACS||Tone bursts||100 dB||500 Hz||Normalised amplitudes of BPPV patients significantly lower than those in the control group|
- Gazioglu S, Boz C. Ocular and cervical vestibular evoked myogenic potentials in multiple sclerosis patients. Clin Neurophysiol. 2012; 123:1872-9. DOI
- Rosengren SM, Welgampola MS, Colebatch JG. Vestibular evoked myogenic potentials: past, present and future. Clin Neurophysiol. 2010; 121:636-51. DOI
- Magliulo G, Iannella G, Gagliardi S. A 1-year follow-up study with C-VEMPs, O-VEMPs and video head impulse testing in vestibular neuritis. Eur Arch Otorhinolaryngol. 2015; 272:3277-81. DOI
- Re M, Gioacchini FM, Salvolini U. Multislice computed tomography overestimates superior semicircular canal dehiscence syndrome. Ann Otol Rhinol Laryngol. 2013; 122:625-31.
- Su CH, Young YH. Differentiating cerebellar and brainstem lesions with ocular vestibular-evoked myogenic potential test. Eur Arch Otorhinolaryngol. 2011; 268:923-30. DOI
- Itoh A, Kim YS, Yoshioka K. Clinical study of vestibular-evoked myogenic potentials and auditory brainstem responses in patients with brainstem lesions. Acta Otolaryngol. 2001; 545:116-9.
- Pollak L, Kushnir M, Stryjer R. Diagnostic value of vestibular evoked myogenic potentials in cerebellar and lower-brainstem strokes. Neurophysiol Clin. 2006; 36:227-33. DOI
- Le TN, Westerberg BD, Lea J. Vestibular neuritis: recent advances in etiology, diagnostic evaluation, and treatment. Adv Otorhinolaryngol. 2019; 82:87-92. DOI
- Strupp M, Brandt T. Vestibular neuritis. Semin Neurol. 2009; 29:509-19. DOI
- Aw ST, Fetter M, Cremer PD. Individual semicircular canal function in superior and inferior vestibular neuritis. Neurology. 2001; 57:768-74. DOI
- Halmagyi GM, Curthoys IS. A clinical sign of canal paresis. Arch Neurol. 1988; 45:737-9. DOI
- Welgampola MS. Evoked potential testing in neuro-otology. Curr Opin Neurol. 2008; 21:29-35. DOI
- Rosengren SM, Colebatch JG, Young AS. Vestibular evoked myogenic potentials in practice: methods, pitfalls and clinical applications. Clin Neurophysiol Pract. 2019; 4:47-68. DOI
- Shin BS, Oh SY, Kim JS. Cervical and ocular vestibular-evoked myogenic potentials in acute vestibular neuritis. Clin Neurophysiol. 2012; 123:369-75. DOI
- Lesmas Navarro MJ, Perez Garrigues H, Morera Perez C. Contribution of the vestibular evoked myogenic potentials to the study of the vestibular neuritis. Acta Otorrinolaringol Esp. 2009; 60:49-5.
- Zhang D, Fan Z, Han Y. Inferior vestibular neuritis: a novel subtype of vestibular neuritis. J Laryngol Otol. 2010; 124:477-81. DOI
- Hong SM, Yeo SG, Kim SW. The results of vestibular evoked myogenic potentials, with consideration of age-related changes, in vestibular neuritis, benign paroxysmal positional vertigo, and Ménière’s disease. Acta Otolaryngol. 2008; 128:861-5. DOI
- Viciana D, Lopez-Escamez JA. Vestibular evoked myogenic potentials and health-related quality of life in patients with vestibular neuritis. Otol Neurotol. 2010; 31:954-8.
- Nola G, Guastini L, Crippa B. Vestibular evoked myogenic potential in vestibular neuritis. Eur Arch Otorhinolaryngol. 2011; 268:1671-7. DOI
- Walther LE, Blödow A. Ocular vestibular evoked myogenic potential to air conducted sound stimulation and video head impulse test in acute vestibular neuritis. Otol Neurotol. 2013; 34:1084-9. DOI
- Hamid MA. Ménière’s disease. Pract Neurol. 2009; 9:157-62. DOI
- Phillips JS, Murdin L, Rea P. Clinical subtyping of Ménière’s disease. Otolaryngol Head Neck Surg. 2018; 159:407-9. DOI
- Okuno T, Sando I. Localization, frequency and severity of endolymphatic hydrops and the pathology of the labyrinthine membrane in Ménière’s disease. Ann Otol Rhinol Laryngol. 1987; 96:438-45. DOI
- Paparella MM. The cause (multifactorial inheritance) and pathogenesis (endolymphatic malabsorption) of Ménière’s disease and its symptoms (mechanical and chemical). Acta Otolaryngol. 1985; 99:445-51. DOI
- Oberman BS, Patel VA, Cureoglu S. The aetiopathologies of Ménière’s disease: a contemporary review. Acta Otorhinolaryngol Ital. 2017; 37:250-63. DOI
- Sajjadi H, Paparella MM. Ménière’s disease. Lancet. 2008; 372:406-14. DOI
- Wu V, Sykes EA, Beyea MM. Approach to Ménière disease management. Can Fam Physician. 2019; 65:463-7.
- Scarpa A, Ralli M, Cassandro C. Low-dose intratympanic gentamicin administration for unilateral Ménière’s disease using a method based on clinical symptomatology: Preliminary results. Am J Otolaryngol. 2019;102289. DOI
- Casani AP, Guidetti G, Schoenhuber R, Consensus Conference Group. Report from a Consensus Conference on the treatment of Ménière’s disease with betahistine: rationale, methodology and results. Acta Otorhinolaryngol Ital. 2018; 38:460-7. DOI
- Maire R, van Melle G. Vestibulo-ocular reflex characteristics in patients with unilateral Ménière’s disease. Otol Neurotol. 2008; 29:693-8. DOI
- de Waele C, Huy PT, Diard JP. Saccular dysfunction in Ménière’s disease. Am J Otol. 1999; 20:223-32.
- Murofushi T, Matsuzaki M, Takegoshi H. Glycerol affects vestibular evoked myogenic potentials in Ménière’s disease. Auris Nasus Larynx. 2001; 28:205-8. DOI
- Xu M, Chen ZC, Wei XY. Evaluation of vestibular evoked myogenic potential, caloric test and cochlear electrogram in the diagnosis of Ménière’s disease. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019; 33:704-8. DOI
- Akkuzu G, Akkuzu B, Ozluoglu LN. Vestibular evoked myogenic potentials in benign paroxysmal positional vertigo and Ménière’s disease. Eur Arch Otorhinolaryngol. 2006; 263:510-7. DOI
- Egami N, Ushio M, Yamasoba T. The diagnostic value of vestibular evoked myogenic potentials in patients with Ménière’s disease. J Vestib Res. 2013; 23:249-57. DOI
- Kingma CM, Wit HP. Asymmetric vestibular evoked myogenic potentials in unilateral Ménière patients. Eur Arch Otorhinolaryngol. 2011; 268:57-61. DOI
- Winters SM, Campschroer T, Grolman W. Ocular vestibular evoked myogenic potentials in response to air-conducted sound in Ménière’s disease. Otol Neurotol. 2011; 32:1273-80. DOI
- Taylor RL, Wijewardene AA, Gibson WP. The vestibular evoked-potential profile of Ménière’s disease. Clin Neurophysiol. 2011; 122:1256-63. DOI
- Rauch SD, Zhou G, Kujawa SG. Vestibular evoked myogenic potentials show altered tuning in patients with Ménière’s disease. Otol Neurotol. 2004; 25:333-8.
- Node M, Seo T, Miyamoto A. Frequency dynamics shift of vestibular evoked myogenic potentials in patients with endolymphatic hydrops. Otol Neurotol. 2005; 26:1208-13.
- Sandhu JS, Low R, Rea PA. Altered frequency dynamics of cervical and ocular vestibular evoked myogenic potentials in patients with Ménière’s disease. Otol Neurotol. 2012; 33:444-9. DOI
- Kim-Lee Y, Ahn JH, Kim YK. Tone burst vestibular evoked myogenic potentials: diagnostic criteria in patients with Ménière’s disease. Acta Otolaryngol. 2009; 129:924-8. DOI
- Katayama N, Yamamoto M, Teranishi M. Relationship between endolymphatic hydrops and vestibular-evoked myogenic potential. Acta Otolaryngol. 2010; 130:917-23. DOI
- Marcelli V. Nystagmus intensity and direction in bow and lean test: an aid to diagnosis of lateral semicircular canal benign paroxysmal positional vertigo. Acta Otorhinolaryngol Ital. 2016; 36:520-6. DOI
- Argaet EC, Bradshaw AP, Welgampola MS. Benign positional vertigo, its diagnosis, treatment and mimics. Clin Neurophysiol Pract. 2019; 4:97-111. DOI
- Casani AP, Cerchiai N, Navari E. Paroxysmal positional vertigo despite complete vestibular impairment: the role of instrumental assessment. Acta Otorhinolaryngol Ital. 2018; 38:563-8. DOI
- Sakaida M, Takeuchi K, Ishinaga H. Long-term outcome of benign paroxysmal positional vertigo. Neurology. 2003; 60:1532-4. DOI
- Prokopakis EP, Chimona T, Tsagournisakis M. Benign paroxysmal positional vertigo: 10-year experience in treating 592 patients with canalith repositioning procedure. Laryngoscope. 2005; 115:1667-71. DOI
- Parnes LS, McClure JA. Free-floating endolymph particles: a new operative finding during posterior semicircular canal occlusion. Laryngoscope. 1992; 102:988-92. DOI
- Boleas-Aguirre M, Sánchez-Ferrándiz N, Artieda J. Vestibular evoked myogenic potentials and benign paroxysmal positional vertigo. Acta Otorrinolaringol Esp. 2007; 58:173-7.
- Yang WS, Kim SH, Lee JD. Clinical significance of vestibular evoked myogenic potentials in benign paroxysmal positional vertigo. Otol Neurotol. 2008; 29:1162-6. DOI
- Korres S, Gkoritsa E, Giannakakou-Razelou D. Vestibular evoked myogenic potentials in patients with BPPV. Med Sci Monit. 2011; 17:CR42-47. DOI
- Lee JD, Park MK, Lee BD. Abnormality of cervical vestibular-evoked myogenic potentials and ocular vestibular-evoked myogenic potentials in patients with recurrent benign paroxysmal postitional vertigo. Acta Otolaryngol. 2013; 133:150-3. DOI
- Yetiser S, Ince D, Gul M. An analysis of vestibular evoked myogenic potentials in patients with benign paroxysmal positional vertigo. Ann Otol Rhinol Laryngol. 2014; 123:686-95. DOI
- Longo G, Onofri M, Pellicciari T. Benign paroxysmal positional vertigo: is vestibular evoked myogenic potential testing useful. Acta Otolaryngol. 2012; 132:39-43. DOI
- Xu H, Liang FY, Chen L. Evaluation of the utricular and saccular function using oVEMPs and cVEMPs in BPPV patients. J Otolaryngol Head Neck Surg. 2016; 45:12. DOI
- Singh NK, Apeksha K. Efficacy of cervical and ocular vestibular-evoked myogenic potentials in evaluation of benign paroxysmal positional vertigo of posterior semicircular canal. Eur Arch Otorhinolaryngol. 2016; 273:2523-32. DOI
- Chang MY, Shin JH, Oh KH. Clinical implication of cervical vestibular evoked myogenic potentials in benign paroxysmal positional vertigo. Clin Neurophysiol. 2017; 128:351-6. DOI
- Hoseinabadi R, Pourbakht A, Yazdani N. The effects of abnormality of cVEMP and oVEMP on rehabilitation outcomes in patients with idiopathic benign paroxysmal positional vertigo. Eur Arch Otorhinolaryngol. 2016; 273:643-8. DOI
- Karataş A, Yüce T, Çebi IT. Evaluation of cervical vestibular-evoked myogenic potential findings in benign paroxysmal positional vertigo. J Int Adv Otol. 2016; 12:316-20. DOI
- Silva TR, de Resende LM, Santos MAR. Combined ocular and cervical vestibular evoked myogenic potential in individuals with vestibular hyporeflexia and in patients with Ménière’s disease. Braz J Otorhinolaryngol. 2017; 83:330-40. DOI
- Chen L, Xu H, Wang WQ. Evaluation of the otolith function using c/oVEMPs in patients with Ménière’s disease. J Otolaryngol Head Neck Surg. 2016; 45:39. DOI
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© Società Italiana di Otorinolaringoiatria e Chirurgia Cervico Facciale , 2019
- Abstract viewed - 3386 times
- PDF downloaded - 1469 times